Recent Posts
- ESMO 2025 Top 10 Breast Cancer Abstracts: 10 Positive Breakthroughs
- TCR-T Therapy: 49% Risk Cut & 39% Response
- ESMO 2025 Top 10 Genitourinary Cancer Must-See Abstracts: 78% rPFS Boost Unveiled
- Immune Checkpoint Inhibitors Myocarditis: 1% Risk, 50% Fatal – UCSF Insights
- TIL Therapy Breakthroughs for Oncologists and Oncology Professionals
Oncology Conference Videos
Oncology News
Why isn’t CAR-T Therapy Revolutionizing the Fight Against GI Cancers? 17 Trial Insights from ASCO GI 2025
Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025,…
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
We recognize that That combination also made them immunogenic. And so there was always recognition. Over time we came to appreciate that when you see the immune system in there where there’s immune lymphocytes in the tumor, those tumors, those patients seem to do better even in the absence of drug therapy and with drug therapy they do better still.
Palbociclib (IBRANCE) Revs Up Metastatic Breast Cancer in PATINA Results Text Version: @DFCI_BreastOnc @Otto_DFCI @OncoAlert…
Metastatic Breast Cancer: Trastuzumab (Herceptin) Factors for Long-Term Remission in HER2 negative
“So basically, we looked at two factors, the one saying the long term remission of…
BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Lead to Longevity Leaps?
BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Really Lead to Longevity Leaps? Text: @OncoAlert…
FGFR2 Mutations and IDH1 Real-World Data Suggests Caution with Immunotherapy in Specific mBTC – ASCO GI Dr. Richard Kim, MD Moffitt Cancer Center
In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP)…
Featured Post
At ASBrS 2025, experts showcased how MRD testing in breast cancer is revolutionizing patient care. Using Natera’s…
SABCS 2024
Warning: Undefined array key "file" in /home2/medicusn/public_html/.website_03b234a0/wp-content/themes/smart-mag/inc/media.php on line 688
Sumanta (Monty) Kumar Pal, MD – Highlights and Insights from MOASC 2024 Summit: Pioneering Oncology Research and Celebrating Young Investigators
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…